From Name:
From Email:
To Name:
To Email:

Optional Message:


New compound could combat castration-resistant prostate cancer

from FierceBiotech

Researchers at Sanford-Burnham Medical Research Institute may have hit on the next big thing in prostate cancer treatment. They've developed a compound called SMIP004 that works by zeroing in on prostate cancer cells and compromising their ability to withstand environmental stress — a trademark of cancer cells. Prostate cancer is the second most common cancer and the second leading cause of cancer-related deaths among men in the United States. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063